免疫检查点签名揭示了高活性多发性硬化症的特定阶段生物标志物

MariPaz López-Molina1, Gabriel Torres Iglesias1, Laura Vidal1

  • 1Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neurology and Cerebrovascular Disease Group, Neuroscience Area of Hospital La Paz Institute for Health Research IdiPAZ, La Paz University Hospital, Universidad Autónoma de Madrid, 28046 Madrid, Spain.

概括

识别像HVEM和CD28这样的免疫细胞标记物可以帮助区分需要早期密集治疗的高度活跃多发性硬化症 (HAMS) 患者,并预测疾病进展. 这有助于个性化治疗策略.